Cargando…
Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
BACKGROUND: Metabolic syndrome (MS) and diabetes mellitus (DM) are risk factors for cardiovascular diseases in general population. However, there was a paucity of studies investigating their impact in primary glomerular diseases (PGD). HYPOTHESIS: MS and concomitant DM are associated with higher ris...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101350/ https://www.ncbi.nlm.nih.gov/pubmed/32469090 http://dx.doi.org/10.1002/clc.23388 |
_version_ | 1783688947492192256 |
---|---|
author | Xie, Zhiyong Li, Zhilian Dong, Wei Chen, Yuanhan Li, Ruizhao Wu, Yanhua Lin, Ting Tao, Yiming Liang, Huaban Wang, Wenjian Liu, Shuangxin Ye, Zhiming Shi, Wei Liang, Xinling |
author_facet | Xie, Zhiyong Li, Zhilian Dong, Wei Chen, Yuanhan Li, Ruizhao Wu, Yanhua Lin, Ting Tao, Yiming Liang, Huaban Wang, Wenjian Liu, Shuangxin Ye, Zhiming Shi, Wei Liang, Xinling |
author_sort | Xie, Zhiyong |
collection | PubMed |
description | BACKGROUND: Metabolic syndrome (MS) and diabetes mellitus (DM) are risk factors for cardiovascular diseases in general population. However, there was a paucity of studies investigating their impact in primary glomerular diseases (PGD). HYPOTHESIS: MS and concomitant DM are associated with higher risk of cardiovascular comorbidity in PGD. METHODS: In a retrospective observational design, we analyzed 3622 hospitalized adult PGD patients and compared the prevalence of cardiovascular comorbidity in non‐MS, MS with and without DM. Risk factors for cardiovascular comorbidity were identified using univariate and multivariate logistic regression. RESULTS: Among 3622 PGD patients, 308 (8.5%) cases accompanied with MS, including 180 (5.0%) patients with DM and 128 (3.5%) without DM. One hundred and sixty four (4.5%) cases coexisted with cardiovascular comorbidity. Patients with MS and concomitant DM exhibited a higher prevalence of cardiovascular comorbidity than those without MS stratified by estimated glomerular filtration rate and pathological types. Logistic regression showed that MS and concomitant DM (OR: 2.496, 95% CI: 1.600‐3.894, P < .001), older age (OR: 1.060, 95% CI: 1.047‐1.074, P < .001), male (OR: 1.536, 95% CI: 1.072‐2.200, P = .019), higher level of serum ti (OR: 1.002, 95% CI: 1.001‐1.003, P < .001), hyperuricemia (OR: 1.901, 95% CI: 1.327‐2.725, P < .001), idiopathic membranous nephropathy (OR: 2.874, 95% CI: 1.244‐6.640, P < .001) and focal segmental glomerulosclerosis (OR: 2.906, 95% CI: 1.147‐7.358, P < .001) were independently associated with a higher risk for cardiovascular comorbidity. CONCLUSIONS: In PGD patients, MS and concomitant DM are associated with an increased risk for cardiovascular comorbidity. More evidence for the causal link between MS/DM and cardiovascular outcomes is needed to be clarified. |
format | Online Article Text |
id | pubmed-8101350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81013502021-05-10 Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study Xie, Zhiyong Li, Zhilian Dong, Wei Chen, Yuanhan Li, Ruizhao Wu, Yanhua Lin, Ting Tao, Yiming Liang, Huaban Wang, Wenjian Liu, Shuangxin Ye, Zhiming Shi, Wei Liang, Xinling Clin Cardiol Clinical Investigations BACKGROUND: Metabolic syndrome (MS) and diabetes mellitus (DM) are risk factors for cardiovascular diseases in general population. However, there was a paucity of studies investigating their impact in primary glomerular diseases (PGD). HYPOTHESIS: MS and concomitant DM are associated with higher risk of cardiovascular comorbidity in PGD. METHODS: In a retrospective observational design, we analyzed 3622 hospitalized adult PGD patients and compared the prevalence of cardiovascular comorbidity in non‐MS, MS with and without DM. Risk factors for cardiovascular comorbidity were identified using univariate and multivariate logistic regression. RESULTS: Among 3622 PGD patients, 308 (8.5%) cases accompanied with MS, including 180 (5.0%) patients with DM and 128 (3.5%) without DM. One hundred and sixty four (4.5%) cases coexisted with cardiovascular comorbidity. Patients with MS and concomitant DM exhibited a higher prevalence of cardiovascular comorbidity than those without MS stratified by estimated glomerular filtration rate and pathological types. Logistic regression showed that MS and concomitant DM (OR: 2.496, 95% CI: 1.600‐3.894, P < .001), older age (OR: 1.060, 95% CI: 1.047‐1.074, P < .001), male (OR: 1.536, 95% CI: 1.072‐2.200, P = .019), higher level of serum ti (OR: 1.002, 95% CI: 1.001‐1.003, P < .001), hyperuricemia (OR: 1.901, 95% CI: 1.327‐2.725, P < .001), idiopathic membranous nephropathy (OR: 2.874, 95% CI: 1.244‐6.640, P < .001) and focal segmental glomerulosclerosis (OR: 2.906, 95% CI: 1.147‐7.358, P < .001) were independently associated with a higher risk for cardiovascular comorbidity. CONCLUSIONS: In PGD patients, MS and concomitant DM are associated with an increased risk for cardiovascular comorbidity. More evidence for the causal link between MS/DM and cardiovascular outcomes is needed to be clarified. Wiley Periodicals, Inc. 2020-05-29 /pmc/articles/PMC8101350/ /pubmed/32469090 http://dx.doi.org/10.1002/clc.23388 Text en © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigations Xie, Zhiyong Li, Zhilian Dong, Wei Chen, Yuanhan Li, Ruizhao Wu, Yanhua Lin, Ting Tao, Yiming Liang, Huaban Wang, Wenjian Liu, Shuangxin Ye, Zhiming Shi, Wei Liang, Xinling Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study |
title | Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study |
title_full | Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study |
title_fullStr | Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study |
title_full_unstemmed | Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study |
title_short | Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study |
title_sort | metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: a retrospective observational study |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101350/ https://www.ncbi.nlm.nih.gov/pubmed/32469090 http://dx.doi.org/10.1002/clc.23388 |
work_keys_str_mv | AT xiezhiyong metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT lizhilian metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT dongwei metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT chenyuanhan metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT liruizhao metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT wuyanhua metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT linting metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT taoyiming metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT lianghuaban metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT wangwenjian metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT liushuangxin metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT yezhiming metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT shiwei metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy AT liangxinling metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy |